Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Current Quality-Pay Programs Unlikely To Reward Device Innovations

This article was originally published in The Gray Sheet

Executive Summary

Under 2015 legislation, CMS is intensely focused on tying payments to quality of care for patients seeing specialists such as gastroenterologists and cardiologists. But because the primary focus of alternative payment plans is on short-term patient outcomes, things like device durability or other long-term impacts from innovation won't easily be rewarded, a Medicare agency official told device-makers May 5.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel